COVID-19 in interstitial lung diseases: are fibrotic ILDs associated with worse outcomes?
M. Serino (Porto, Portugal), B. Martins (Porto, Portugal), M. Martins (Porto, Portugal), C. Valente (Porto, Portugal), I. Carvalho (Porto, Portugal), M. Barbosa (Barreiro-Montijo, Portugal), M. Alves (Lisboa, Portugal), C. Cascais (Aveiro, Portugal), A. Terras Alexandre (Porto, Portugal), N. Melo (Porto, Portugal), P. Caetano Mota (Porto, Portugal), A. Morais (Porto, Portugal), H. Novais-Bastos (Porto, Portugal)
Source: International Congress 2022 – Interstitial lung diseases diagnosis in the COVID-19 era: new tools for new challenges
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Serino (Porto, Portugal), B. Martins (Porto, Portugal), M. Martins (Porto, Portugal), C. Valente (Porto, Portugal), I. Carvalho (Porto, Portugal), M. Barbosa (Barreiro-Montijo, Portugal), M. Alves (Lisboa, Portugal), C. Cascais (Aveiro, Portugal), A. Terras Alexandre (Porto, Portugal), N. Melo (Porto, Portugal), P. Caetano Mota (Porto, Portugal), A. Morais (Porto, Portugal), H. Novais-Bastos (Porto, Portugal). COVID-19 in interstitial lung diseases: are fibrotic ILDs associated with worse outcomes?. 444
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|